Intubeaze 20 mg/ml Solution pour pulvérisation laryngopharyngée pour chats
Intubeaze 20 mg/ml Solution pour pulvérisation laryngopharyngée pour chats
Authorised
- Lidocaine hydrochloride monohydrate
Product identification
Medicine name:
Intubeaze 20 mg/ml Solution pour pulvérisation laryngopharyngée pour chats
Intubeaze 20 mg/ml Spray zur Anwendung im Rachen und am Kehlkopf, Lösung
Active substance:
- Lidocaine hydrochloride monohydrate
Target species:
-
Cat
Route of administration:
-
Laryngopharyngeal use
Product details
Active substance and strength:
-
Lidocaine hydrochloride monohydrate20.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Laryngopharyngeal spray, solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QR02AD02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Package description:
- A clear, colourless Type I glass vial with a polypropylene and polyethylene spray pump and actuator containing 10 ml. Vial packaged in a cardboard box.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Genera d.d.
Responsible authority:
- Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
- V 914/19/03/1742
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 3/07/2023
